Contemporary Amperex Technology submitted a listing application to the Hong Kong Stock Exchange, with fundraising directed towards a project in Hungary | Quick read announcement.
1. Contemporary Amperex Technology Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with sponsors and coordinators including Bank of America, CICC, JPMorgan, Goldman Sachs, UBS Group, and others; 2. According to the application materials, part of the funds raised from the Hong Kong stock listing will be used to promote the first and second phases of the Hungary project.
Contemporary Amperex Technology is making a push for the Hong Kong Stock Exchange.
Accelerate the pace of going abroad.
A major reveal of A-share performance in 2024: China Life Insurance earns over 100 billion to claim the title of 'Profit King', and the list of the top 20 pre-profit stocks is here.
① The performance forecast disclosure for A-share listed companies for 2024 has concluded, with China Life Insurance earning a whopping 112.6 billion yuan and claiming the title of "profit king"; ② Attached is the list of the top 20 stocks by performance profit for the 2024 annual report (attached table).
Net profit growth exceeds 70%, and the insurance industry's performance growth rate is on track to break a decade record.
Another listed insurance company has disclosed a "good news" report. On January 24, The People's Insurance announced that the company achieved a net profit attributable to the parent of 398.53-...
Target Price raised by 33%! JPMorgan is bullish on Contemporary Amperex Technology: technological innovation and global market expansion drive growth.
JPMorgan believes that due to the accelerated growth in sales, potential increases in unit economic efficiency, and its position as a CSI Leading Technology Index, the core competitive advantages of Contemporary Amperex Technology are promising. The target price has been significantly raised from 300 yuan to 400 yuan, indicating a potential increase of 53.9% compared to Tuesday's closing price.
Under the new accounting standards, performance fluctuations have increased! New China Life Insurance turned a loss into profit year-on-year in the fourth quarter of last year, but performance dropped sharply compared to the previous quarter.
①The net income for 2024 is expected to increase from 23.958 billion yuan to 25.7 billion yuan, a year-on-year growth of 175% to 195%; ②In the first three quarters of 2024, New China Life Insurance's investment income and fair value change income totaled 47.119 billion yuan; ③With the recovery of the capital markets and the increase in the proportion of equity asset allocation, New China Life Insurance's investment returns have surged.